Extrahepatic manifestations of infection with hepatitis C virus

Clinics in Liver Disease

Volumn 5, Issue 4, 2001, Pages 979-1008

  Mehta, Savant ^a   Levey, John M ^a,b   Bonkovsky, Herbert L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b St Vincent's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PORPHYRIN DERIVATIVE; RIBAVIRIN;

AUTOIMMUNE DISEASE; DISEASE EXACERBATION; HASHIMOTO DISEASE; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; LEUKOCYTOCLASTIC VASCULITIS; LIVER CELL; OXIDATIVE STRESS; PORPHYRIA CUTANEA TARDA; RASH; REVIEW; SKIN DISEASE;

EID: 0034783227     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70205-1     Document Type: Article

References (60)

1. Porphyria cutanea tarda and HLA-linked hemochromatosis-all in the family?
2. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia
3. Hypervariable region sequence in cryoglobulin associated hepatitis C virus in sera of patients with chronic hepatitis C: Relationship to antibody response against hypervariable region genome
4. Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection?
5. Erythema multiforme and hepatitis C
6. Porphyrin and heme metabolism and the porphyrias
7. Disorders of iron overload (hemochromatosis) and porphyria cutanea tarda
8. The porphyrias
9. Diagnosis of porphyric syndromes: A practical approach in the era of molecular biology
10. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America
11. The porphyrias
12. Porphyrin metabolism disorders in patients with chronic hepatitis C infections
13. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients
14. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa
15. Pruritus as a presenting symptom of chronic hepatitis C
16. High prevalence of serologicai markers of autoimmtmity in patients with chronic hepatitis C
17. Immunofluorescent studies of skin in cryoglobulinemic vasculitis
18. Immunologic features and HLA associations in chronic viral hepatitis
19. Necrolytic acral erythema: A cutaneous marker of hepatitis C
20. Erythema nodosum and hepatitis C
21. Porphyria cutanea tarda
22. Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association
23. Clinicai, biochemical, and histologicai changes in hepatitis C virus infection-associated cryoglobulinemia
24. Association between hepatitis C virus and mixed cryoglobulinemia
25. Interferon-α in mixed cryoglobulinemia patients. A randomized crossover-controlled trial
26. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia
27. Latent auto-immune hepatitis triggered during interferon therapy in patients with chronic hepatitis C
28. Exacerbation of psoriasis due to interferon-α treatment of chronic active hepatitis
29. Mixed cryoglobulinemia: Clinical aspects and long term follow-up of 40 patients
30. Hepatitis C virus (HCV)-infection and oral lichen planus
31. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease
32. Disorders of porphyrin metabolism
33. Is hepatitis C virus infection a trigger of porphyria cutanea tarda?
34. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection
35. Lichen planus and hepatitis C virus-related chronic active hepatitis
36. Association of prurigo with hepatitis C virus infection
37. Sjogren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection
38. Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda
39. Mixed cryoglobulinemia in chronic hepatitis C infection: A clinicopathologic analysis of 10 cases and review of recent literature
40. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis
41. Primary liver cancer, other malignancies, and mortality risks following porphyria: A cohort study in Denmark and Sweden
42. Oral lichen planus and HCV infection: A clinical evaluation of 263 cases
43. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: The influence of virus C infection
44. Thrombocytopenia associated with hepatitis C viral infection
45. Lichen planus and hepatitis C virus in the northern region of Japan
46. Hyde's prurigo nodularis and chronic HCV hepatitis
47. Immunological disorders in C virus chronic active hepatitis: A prospective case-controlled study
48. Urticaria and hepatitis C
49. The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda
50. A lethal course of hepatitis C, glomerulonephritis, and pulmonary vasculitis unresponsive to interferon treatment
51. High prevalence of hepatitis C virus type 1b in Italian patients with porphyria cutanea tarda
52. Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda
53. The rheumatoid factor response in the etiology of mixed cryoglobulins associated with hepatitis C virus infection
54. In vitro reactivity of cryoglobulin IgM and IgG in hepatitis C virus associated mixed cryoglobulinemia
55. Acute exacerbation of liver disease during interferon-α therapy for chronic hepatitis C
56. High prevalence of cutaneous reactions to interferon alpha plus ribavirin combination therapy in patients with chronic hepatitis C virus
57. Autoantibodies in porphyria cutanea tarda: A controlled study
58. Experimental liver cirrhosis induced by alcohol and iron
59. Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome
60. Hypergammaglobulinemic purpura associated with Sjogrens syndrome and chronic C type hepatitis